Free radicals, or more specifically, reactive oxygen species (ROS), have been proposed as critical mediators of dysfunction and disease for a large number of disorders, including many in the brain related to Alzheimer's disease, accelerated aging, other neurodegenerative diseases, severe mental illnesses and vascular disease. However, there are simply no methods of assessing ROS levels in human tissue. We believe this has created an unmet need for an imaging approach that could quantify and monitor levels of mitochondrial and inflammatory ROS in brain. We have therefore developed a set of novel positron emission tomography (PET) tracers that allow direct assessment of ROS based on their behavior and similarity to dihydroethidine (DHE), an optical probe that is well validated for imaging ROS in animals. Based on recently acquired, highly encouraging data, we believe that, as detailed in the Specific Aims and Research Plan sections, these tracers will translate to direct applications in human brain imaging. Furthermore, we believe that a major application will be in improving our understanding of Alzheimer's disease pathology and providing assistance in designing appropriate disease-modifying treatments.

Public Health Relevance

This proposal intends to develop a method for using a PET scanner to image oxygen-based free radical levels in the human brain. Free radicals are small molecules in the body that are extremely reactive and when elevated they may injure the body by altering proteins and other important chemicals. As free radicals may be involved in many diseases, including Alzheimer's disease, a method to allow scientists and clinical investigators a way to monitor levels of free radicals should greatly increase our understanding of how injury to the brain occurs in these diseases, and how treatments for these disorders could be developed faster.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
NIH Challenge Grants and Partnerships Program (RC1)
Project #
5RC1AG036045-02
Application #
7939577
Study Section
Special Emphasis Panel (ZRG1-BDA-A (58))
Program Officer
Wise, Bradley C
Project Start
2009-09-30
Project End
2012-08-31
Budget Start
2010-09-01
Budget End
2012-08-31
Support Year
2
Fiscal Year
2010
Total Cost
$495,848
Indirect Cost
Name
Washington University
Department
Radiation-Diagnostic/Oncology
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Chu, Wenhua; Chepetan, Andre; Zhou, Dong et al. (2014) Development of a PET radiotracer for non-invasive imaging of the reactive oxygen species, superoxide, in vivo. Org Biomol Chem 12:4421-31
Zhou, Dong; Chu, Wenhua; Dence, Carmen S et al. (2012) Highly efficient click labeling using 2-[¹?F]fluoroethyl azide and synthesis of an ¹?FN-hydroxysuccinimide ester as conjugation agent. Nucl Med Biol 39:1175-81
Ances, B M; Christensen, J J; Teshome, M et al. (2010) Cognitively unimpaired HIV-positive subjects do not have increased 11C-PiB: a case-control study. Neurology 75:111-5
Roe, C M; Mintun, M A; Ghoshal, N et al. (2010) Alzheimer disease identification using amyloid imaging and reserve variables: proof of concept. Neurology 75:42-8